Description
Tesamorelin + Ipamorelin is a research peptide blend combining two synthetic peptides studied in laboratory settings for their interactions with growth hormone–related signaling pathways. Tesamorelin is a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a growth hormone secretagogue receptor (GHSR) agonist.
This combination provides researchers with a convenient formulation for investigating the two compounds together in controlled experimental models. Research involving this blend remains investigational and should not be interpreted as evidence of established therapeutic benefit.
Product Details
- Tesamorelin: 12 mg
- Ipamorelin: 6 mg
- Total peptide content: 18 mg
- Vial size: 3 mL
- Research-grade peptide blend
- Red Rock Labs research product
Research Areas
Tesamorelin and Ipamorelin have been studied in experimental research involving:
- GHRH and GHSR receptor signaling
- Growth hormone–related pathways
- Pituitary and endocrine signaling
- Peptide-receptor interactions
- Cellular and molecular physiology
- Experimental metabolic and endocrine research
Storage & Handling
Store according to the product’s validated stability specifications. Protect from excessive heat, light, and moisture. Appropriate laboratory handling and contamination-control procedures should be followed.
FOR RESEARCH USE ONLY
Not for human consumption, therapeutic use, or veterinary use.
This product is intended exclusively for laboratory and scientific research. It is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.